phosphatidylcholines has been researched along with capecitabine in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (capecitabine) | Trials (capecitabine) | Recent Studies (post-2010) (capecitabine) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 5,318 | 1,719 | 3,282 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arshad, A; Bowrey, DJ; Calder, PC; Dennison, AR; Eltweri, AM; Fisk, HL; Thomas, AL | 1 |
1 other study(ies) available for phosphatidylcholines and capecitabine
| Article | Year |
|---|---|
Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Epirubicin; Erythrocyte Membrane; Erythrocytes; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Feasibility Studies; Female; Fish Oils; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Phosphatidylcholines; Pilot Projects; Prospective Studies; Reproducibility of Results; Sample Size; Stomach Neoplasms; Treatment Outcome; United Kingdom | 2017 |